Royal Bank of Canada »

Y Mabs Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 837 0.00
2023-12-31 $71k 10k 6.81
2023-09-30 $0 5.5k 0.00
2023-06-30 $0 3.1k 0.00
2022-12-31 $40k 8.7k 4.65
2022-09-30 $84k 5.8k 14.50
2021-06-30 $541k 15k 36.36
2021-03-31 $308k 10k 30.52
2020-12-31 $437k 8.8k 49.47
2020-09-30 $286k 7.4k 38.46
2020-06-30 $243k 5.6k 43.13
2020-03-31 $3.0k 116 25.86
2019-12-31 $19k 619 31.00